Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.

Front Immunol

Pathogen-Host-Environment Interactions Research Laboratory, Institute of Biology, College of Science, University of the Philippines Diliman, Quezon City, Philippines.

Published: June 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.878943.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235355PMC
http://dx.doi.org/10.3389/fimmu.2022.948031DOI Listing

Publication Analysis

Top Keywords

corrigendum progress
4
progress recombinant
4
recombinant influenza
4
influenza vaccine
4
vaccine development
4
development heterosubtypic
4
heterosubtypic immune
4
immune response
4
response [this
4
[this corrects
4

Similar Publications

Corrigendum to "High glucose-induced mitochondrial fission drives pancreatic cancer progression through the H3K18la/TTK/BUB1B signal pathway" [Cell Signal, 135 (2025), 112027].

Cell Signal

August 2025

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Fujian Medical University, 350005, China; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, 350005, China; Institute of Abdominal Surgery,

View Article and Find Full Text PDF

[Corrigendum] Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.

Oncol Rep

November 2025

Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.

Subsequently to the publication of the above paper, the authors contacted the Editor to explain that, concerning the cell invasion assay experiments shown in Fig. 4, and due to an error made in filing the data, the image featured for the OA group / MGC803 cellular experiment in Fig. 4C had been inadvertently duplicated from the invasion image showing the shSET group / SGC7901 cellullar experiment in Fig.

View Article and Find Full Text PDF

[Corrigendum] Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.

Oncol Rep

November 2025

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato‑Pancreato‑Biliary Surgery, Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.

Subsequently to the publication of the above paper, the authors contacted the Editorial Office to explain that, for the Transwell migration and invasion assay experiments shown in Fig. 4 on p. 573, the data panel for the '94T778 / Lenti‑shTYMS‑1' experiment shown in Fig.

View Article and Find Full Text PDF